Impact of early release of oral investigational prescriptions on safety and efficiency at a comprehensive cancer center.

Authors

null

Alan H. Breaud

Dana–Farber Cancer Institute, Boston, MA

Alan H. Breaud, Audrea H Szabatura, Laura Cedro, Anna Shanedling, Hakim Lakhani, Caryn Caparrotta, Teresa Mazeika, Garrett Rompelman, Amy Gallant, Khanh Tu Do, Sylvia Bartel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session B: Patient Experience; Safety; Technology and Innovation in Quality of Care

Track

Patient Experience,Technology and Innovation in Quality of Care,Safety

Sub Track

Standardization Efforts to Improve Safety

Citation

J Clin Oncol 37, 2019 (suppl 27; abstr 257)

DOI

10.1200/JCO.2019.37.27_suppl.257

Abstract #

257

Poster Bd #

G8

Abstract Disclosures

Similar Posters

First Author: Marina D. Kaymakcalan

First Author: Lalan S. Wilfong

Poster

2021 ASCO Quality Care Symposium

Implementation of an oral chemotherapy adherence tool at an NCCN comprehensive cancer center.

Implementation of an oral chemotherapy adherence tool at an NCCN comprehensive cancer center.

First Author: Peter D. Whooley

Poster

2019 ASCO Quality Care Symposium

Pharmacist-driven oral oncolytic medication education and consent.

Pharmacist-driven oral oncolytic medication education and consent.

First Author: Bernard Tawfik